Antimicrobial-resistant infections
Latest News
Antimicrobial resistance requires a manifold response
In addition to finding new antibiotics, efforts to tackle this public health threat also should be directed toward promoting more rational...
News from the FDA/CDC
Cases of potentially deadly fungus jump 200%: CDC
People in hospitals and nursing homes are at a heightened risk because they might have weakened immune systems or be using invasive medical...
News from the FDA/CDC
Drug-resistant stomach bug infections on the rise: CDC
Most infections have been seen in men who have sex with men, but a small number have also occurred in women and in young children.
Latest News
Doxy PEP does not lower risk of STIs in cisgender women
Women are known to be at higher risk of infection because the lining of the vagina is thinner than the skin of the penis, allowing for easier...
News from the FDA/CDC
FDA broadens warning on potentially contaminated eye products
An announcement released Wednesday adds to a...
Commentary
Must-read acute care medicine articles from 2022
“When 2022 began, we started seeing some light at the end of the COVID-19 tunnel.”
From the Journals
Multidrug-resistant gram-negative infections treatable with newer antibiotics, but guidance is needed
They found that these infections were the second leading cause of death worldwide.
News
FDA OKs first fecal transplant therapy for recurrent C. difficile
The application for Rebyota received priority review and had orphan drug and breakthrough therapy designation.
Feature
Don’t let amoxicillin shortage go to waste, antibiotic stewards say
The amoxicillin shortage stands out because of how widely the drug is used and the fact that the shortage appears to have been sparked by an...
Latest News
Promising new antibiotic emerges for treating UTIs
It would be the first new treatment in 20 years for UTIs, which affect more than half of women at least sometime in their lives.
From the Journals
Oral FMT on par with colonic FMT for recurrent C. difficile
“We present one of the largest cohorts involving people who received capsule FMT.”